Analystreport

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) was given a new $453.00 price target on by analysts at Leerink Swann. They now have a "buy" rating on the stock.

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com